by Roland Stieger | Nov 28, 2016
Staburo took part in this year’s BVMA symposium on 25 November 2016, at the Sheraton München Arabellapark Hotel, here in Munich.
The BVMA represents the interests of the German CROs. The member companies maintain a lively exchange of information on all topics which are of particular importance to the CRO branch, e.g. on
- Questions of liability and insurance
- Education and training
- Quality requirements and
- Trends in the pharmaceutical and CRO industry
We also attended the get-together on 24 November 2016, at the Sheraton München Arabellapark Hotel, where we met current partners and other companies that currently need biostatistics support.
This year’s sessions gave a great update on regulatory news, risk-based clinical research and advanced study designs. Especially the latter was very interesting for us, since we see an increasing demand from our clients in this field and build up a very good expertise in recent years, e.g. in adaptive/Bayesian designs.
Big thank you to the great organization of this event, despite the interfering Lufthansa strike!
by Roland Stieger | Nov 20, 2016
In this talk, important aspects of pharmacokinetics (PK) and pharmacodynamics (PD) were presented. Four elements of PK (ADME) were discussed in detail. Biopharmaceutical classification system (BCS), 2-compartment distribution model, destructive and conjugative reactions and the elimination phase of drugs were discussed for ADME trials. Some PK parameters were also listed and described. The second part of this talk was about pharmacodynamics, where the onset, duration and mechanism of actions were presented. In addition, some PD concepts such as ED50, efficacy and potency were discussed.
by Roland Stieger | Nov 14, 2016
The website biologenkompass.de published a story about our Business Development Manager Roland Stieger (in German).
The interview was done by Ulrike Herzog, who is one of the founders of biologenkompass.de. The goal of her team is to inform biologists with potential job opportunities after their Master’s degree or PhD thesis.
We are very happy to support them in their project and thank biologenkompass.de for the interview!
by Roland Stieger | Nov 10, 2016
Staburo took part in the 2016 BIO Europe Conference in Cologne between 7 and 9 November.
The conference featured a wide range of interesting topics for statisticians in the pharmaceutical and healthcare industry, including health technology assessment, biomarkers in translational medicine and general trends in drug development. Presenters from industry, academia and regulatory agencies shared their knowledge in talks and discussion rounds.
The most valuable feature of this conference was once again the partneringONE section, where we took the opportunity to meet potential partners face-to-face and learn about other their need in biostatistics. We will definitely be in Berlin for next years BIO Europe!